BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36472189)

  • 1. Population-Based Epidemiology of Heart Failure in a Low-Income Country: The Haiti Cardiovascular Disease Cohort.
    Kingery JR; Roberts NL; Lookens Pierre J; Sufra R; Dade E; Rouzier V; Malebranche R; Theard M; Goyal P; Pirmohamed A; Yan LD; Hee Lee M; Nash D; Metz M; Peck RN; Safford MM; Fitzgerald D; Deschamps MM; Pape JW; McNairy M
    Circ Cardiovasc Qual Outcomes; 2023 Feb; 16(2):e009093. PubMed ID: 36472189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of prevalent cardiovascular diseases in urban Port-au-Prince, Haiti: a population-based cross-sectional study.
    Yan LD; Sufra R; St Sauveur R; Jean-Pierre MC; Apollon A; Malebranche R; Théard M; Pierre G; Dévieux J; Lau J; Mourra N; Roberts NLS; Rasul R; Nash D; Pirmohamed AM; Devereux RB; Lee MH; Kwan GF; Safford MM; Adrien L; Alfred JP; Deschamps M; Severe P; Fitzgerald DW; Pape JW; Rouzier V; McNairy ML;
    Lancet Reg Health Am; 2024 May; 33():100729. PubMed ID: 38590326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Lead Exposure Associated With Higher Blood Pressure in Haiti: a Warning Sign for Low-Income Countries.
    Yan LD; Rouzier V; Pierre JL; Lee MH; Muntner P; Parsons PJ; Apollon A; St-Preux S; Malebranche R; Pierre G; Emmanuel E; Nash D; Kingery J; Walsh KF; Smith CE; Metz M; Tymejczyk O; Deschamps M; Pape JW; Fitzgerald DW; McNairy ML
    Hypertension; 2022 Jan; 79(1):283-290. PubMed ID: 34878898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neighborhood Social Vulnerability and Premature Cardiovascular Disease in Haiti.
    Roberts NLS; Sufra R; Yan LD; St Sauveur R; Inddy J; Macius Y; Théard M; Lee MH; Mourra N; Rasul R; Nash D; Deschamps MM; Safford MM; Pape JW; Rouzier V; McNairy ML
    JAMA Cardiol; 2024 Jun; ():. PubMed ID: 38837139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort.
    Lookens J; Tymejczyk O; Rouzier V; Smith C; Preval F; Joseph I; Baptiste RJ; Victor J; Severe P; Apollon S; Dumont E; Forestal G; St Preux S; Rivera V; Seo G; Charles B; Ariste W; Kingery J; Devieux J; Koenig S; Nash D; Fitzgerald D; Safford M; Deschamps MM; Pape J; McNairy M
    BMC Public Health; 2020 Nov; 20(1):1633. PubMed ID: 33131500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Epidemiology Among Adults in Port-au-Prince, Haiti: A Cross-Sectional Study.
    Sufra R; Lookens Pierre J; Dade E; Rouzier V; Apollon A; St Preux S; Préval F; Inddy J; Metz M; Tymejczyk O; Nash D; Malebranche R; Deschamps M; Pape JW; Goncalves MD; McNairy ML; Yan LD
    Front Endocrinol (Lausanne); 2022; 13():841675. PubMed ID: 35282460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country.
    Yan LD; Rouzier V; Pierre JL; Dade E; Sufra R; Huffman MD; Apollon A; St Preux S; Metz M; Sabwa S; Morisset B; Deschamps M; Pape JW; McNairy ML
    Front Epidemiol; 2022; 2():. PubMed ID: 36816341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Adiposity and Risk of Heart Failure and Mortality: The Jackson Heart Study.
    Rao VN; Bush CG; Mongraw-Chaffin M; Hall ME; Clark D; Fudim M; Correa A; Hammill BG; O'Brien E; Min YI; Mentz RJ
    J Am Heart Assoc; 2021 Jul; 10(14):e020920. PubMed ID: 34238024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
    Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
    Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
    Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
    Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction.
    Berg DD; Jhund PS; Docherty KF; Murphy SA; Verma S; Inzucchi SE; Køber L; Kosiborod MN; Langkilde AM; Martinez FA; Bengtsson O; Ponikowski P; Sjöstrand M; Solomon SD; McMurray JJV; Sabatine MS
    JAMA Cardiol; 2021 May; 6(5):499-507. PubMed ID: 33595593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.
    Lopes RD; Alexander KP; Stevens SR; Reynolds HR; Stone GW; Piña IL; Rockhold FW; Elghamaz A; Lopez-Sendon JL; Farsky PS; Chernyavskiy AM; Diaz A; Phaneuf D; De Belder MA; Ma YT; Guzman LA; Khouri M; Sionis A; Hausenloy DJ; Doerr R; Selvanayagam JB; Maggioni AP; Hochman JS; Maron DJ
    Circulation; 2020 Nov; 142(18):1725-1735. PubMed ID: 32862662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.